Greenstone Biosciences accelerates drug discovery through human-relevant NAMs and advanced AI technologies. By combining scientific expertise with innovative platforms, we deliver safer, more effective therapies to patients in less time.

Webinars

Have Questions?

Quick Links

Services

Contact Us

Webinars

A Fully iPS Cell Based Model of the Blood Brain Barrier

Human Pluripotent Stem Cells, Organoids, and Drug Discovery

Using Complex Human iPSC-Cardiomyocyte Models of Heart Disease to Assess Pathogenicity of Genetic Variants and Develop Novel Therapeutics

iPSC-based Models of Heart Disease

New Alternative Methodology (NAM) for Pre-Clinical Cardiac Safety Screening

NAMs: Bringing Human Biology to the Earliest Stages of Drug Discovery Programs Using Patient iPSCs

Have Questions?

Quick Links

Services

Contact Us